Related Experiment Video
Updated: Nov 18, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Elevated circulating growth differentiation factor 15 is related to decreased heart rate variability in chronic
Lulu Wang1, Jing Luo1, Wenjin Liu2
1Center for Kidney Disease, 2nd Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Insights
Increased Growth Differentiation Factor 15 (GDF15) in chronic kidney disease (CKD) patients is linked to reduced heart rate variability (HRV). Further research is needed to understand GDF15
Area of Science:
- Cardiovascular Research
- Nephrology
- Biomarkers
Background:
- Growth Differentiation Factor 15 (GDF15) is a transforming growth factor beta superfamily member.
- Elevated GDF15 levels are associated with cardiovascular disease risk.
- The specific impact of GDF15 on the cardiovascular system in chronic kidney disease (CKD) patients requires further investigation.
Purpose of the Study:
- To analyze the detailed effect of GDF15 on the cardiovascular system in patients with CKD.
- To investigate the association between plasma GDF15 concentrations and cardiovascular parameters in CKD patients.
Main Methods:
- Study included 355 non-dialysis CKD patients.
- Assessed blood pressure, endothelial function, pulse wave velocity, and heart rate variability (HRV).
- Measured plasma GDF15 concentration using enzyme-linked immunosorbent assay.
Main Results:
- Higher plasma GDF15 concentrations correlated with decreased estimated glomerular filtration rate (eGFR) and increased urine protein-to-creatinine ratio (uPCR).
- Multivariable analysis revealed a negative association between plasma GDF15 and HRV parameters (SDNN, RMSSD, Triangular Index).
- Mean GDF15 level was 1394.7 (±610.1) pg/mL in participants with a mean eGFR of 50.1 (±33.2) mL/min/1.73m².
Conclusions:
- A significant link exists between elevated plasma GDF15 and reduced heart rate variability (HRV) in CKD patients.
- The underlying mechanisms and predictive value of GDF15 in cardiovascular disease within the CKD population warrant further study.
Background:
Growth differentiation factor 15(GDF15) is a distant member of the superfamily of the transforming growth factor beta (TGF-β). It has been established that increased GDF15 levels are associated with an increased risk of cardiovascular disease. However, the detail effect of GDF15 on cardiovascular system in patients with chronic kidney disease (CKD) needs detail analysis.
Methods:
Patients with CKD who did not need dialysis were enrolled in the study. Blood pressure (BP), endothelial function, pulse wave velocity (PWV) and heart rate variability (HRV) were taken in all subjects. Plasma GDF15 concentration was measured by an enzyme-linked immunosorbent assay.
Results:
Among the 355 participants, the mean age was 57.4 (±14.2) years old and the mean estimated glomerular filtration rate (eGFR) was 50.1 (±33.2) mL/min/1.73m2. The average plasma GDF15 level was 1394.7 (±610.1) pg/mL. Higher GDF15 concentrations were significantly associated with decreased eGFR and increased urine protein-to-creatinine ratio (uPCR). In multivariable models, after adjusting for potential confounders, plasma GDF15 has negative concerning with HRV parameters including the standard deviation of the normal-to-normal (NN) interval (SDNN), the square root of the mean of the sum of the squares of differences between adjacent NN intervals (RMSSD) and Triangular Index.
Conclusion:
We observed there was a link between increased plasma of GDF15 and decreased HRV. The mechanisms and prediction of GDF15 in the cardiovascular disease with CKD needs further discussion and study.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Heart Failure Drugs: Diuretics

